Confluent Biotech Capital Partners, LP — Form D/A
Confluent Biotech Capital Partners, LP of TEANECK, NJ, a pooled investment fund, filed a Form D amendment with the SEC on 2018-09-19. $1.3M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2018-09-19
- Form: D/A
- Accession: 0001013594-18-000537
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $1.3M
- Minimum investment: $250K
- Investors: 5
- Date of first sale: 2014-01-01
- Security types: equity, fund interests
- SEC file number: 021-247837
Issuer
- Name: Confluent Biotech Capital Partners, LP
- CIK: 0001651358
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 1290 TRAFALGAR STREET, TEANECK, NJ, 07666
- Phone: 201-357-4203
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Daniel Brothman | Director | Teaneck, NJ |
| Daniel Brothman | Executive Officer | Teaneck, NJ |
| Daniel Brothman | Promoter | Teaneck, NJ |
| Steven Furer | Director | Teaneck, NJ |
| Steven Furer | Executive Officer | Teaneck, NJ |
| Steven Furer | Promoter | Teaneck, NJ |
Other filings by this issuer (4)
More